Investor mix
8 investors on record; 1 has since exited.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 5 | 63% |
| Private equity | 2 | 25% |
| Other / undisclosed | 1 | 13% |
Developer of therapeutics for the treatment of cancer
8 investors on record; 1 has since exited.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 5 | 63% |
| Private equity | 2 | 25% |
| Other / undisclosed | 1 | 13% |